Xue Shi

2.3k citations
52 papers · 1.9k indexed · h-index 24
Topics
Metabolomics and Mass Spectrometry Studies (13 papers)Analytical Chemistry and Chromatography (8 papers)Liver Disease Diagnosis and Treatment (8 papers)

In The Last Decade

Xue Shi

48 papers receiving 1.9k citations

Peers

Xue Shi
Comparison fields: 5 of 131
  • Molecular Biology 773
  • Epidemiology 475
  • Pathology and Forensic Medicine 303
  • Biomedical Engineering 246
  • Spectroscopy 216
Replace Francisco J. Rupérez with:
Francisco J. Rupérez Spain
Kazunari Tanaka Japan
Hiroyuki Shimasaki Japan
Masaru Kunitomo Japan
Xiaoli Wei China
Neil W. Kooy United States
Yunlun Li China
M.Saadeh Suleiman United Kingdom
David V. Godin Canada
Yuhong Li China
Xue Shi relative to Francisco J. Rupérez Spain Francisco J. Rupérez's profile →
Citations per field
00.5×3.4×
Francisco J. Rupérez · 1×
Citations per year

Countries citing papers authored by Xue Shi

Since Specialization
Citations

This map shows the geographic impact of Xue Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Shi more than expected).

Fields of papers citing papers by Xue Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Shi. The network helps show where Xue Shi may publish in the future.

Co-authorship network of co-authors of Xue Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Shi. A scholar is included among the top collaborators of Xue Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Shi. Xue Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 8
4 10
5 14
6 33
7 13
8 78
9 8
10 17
11 11
12 79
13 1
14 9
15 7
16 56
17 65
18 22
19 41
20
Structural and SP1-binding Analysis of Promoter of LAPTM4β, A Novel Gene Associated with Hepatocellular Carcinoma
1

About Xue Shi

Xue Shi is a scholar working on Neurology, Geriatrics and Gerontology and Health Informatics, having authored 52 papers that have together received 1.9k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (13 papers), Analytical Chemistry and Chromatography (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (303 citations), Epidemiology (475 citations) and Bioengineering (76 citations). Xue Shi has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiang Zhang, Seongho Kim, Craig J. McClain, Xiaoli Wei, Xinmin Yin, Imhoi Koo, Yan Zhao, Jihong Yao, Yunan Tang and Zhanxiang Zhou. Their work appears in journals such as Bioinformatics, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026